Thomas Reiberger (@reibergerthomas) 's Twitter Profile
Thomas Reiberger

@reibergerthomas

Professor of Hepatology @MedUni_Wien
Director CD-Lab for #PortalHypertension & #LiverFibrosis
Adjunct PI @CeMM_News & @LBI_RUD
Head @CrgMOTION
Secr @BavenoCoop

ID: 1420491277813047296

linkhttp://www.liver.at calendar_today28-07-2021 21:08:35

1,1K Tweet

2,2K Followers

629 Following

Thomas Reiberger (@reibergerthomas) 's Twitter Profile Photo

The The Baveno Cooperation: an EASL Consortium TrackHub at EASLnews congress #2025 was packed. 🔥 news on #PortalHypertension 🔗 bavenocoop.net 🆕 BavenoVIII consensus in #2026: 27-28 March ➡️ baveno8.org

The <a href="/BavenoCoop/">The Baveno Cooperation: an EASL Consortium</a> TrackHub at <a href="/EASLnews/">EASLnews</a> congress #2025 was packed. 🔥 news on #PortalHypertension

🔗 bavenocoop.net
🆕 BavenoVIII consensus in #2026: 27-28 March
➡️ baveno8.org
EASL Education (@easledu) 's Twitter Profile Photo

EASLnews Debbie Shawcross Thomas Reiberger Thomas Berg Ahmed Elsharkawy Dr.Bornie #Decompensation was once seen as the end of the road.🛣️ Now we know that even patients with decompensated liver disease can improve, and sometimes even reverse cirrhosis. 💡We are starting to understand the mechanisms driving this shift. EASLnews #EASLstudio #EASLcongress

<a href="/EASLnews/">EASLnews</a> <a href="/DebbieShawcros1/">Debbie Shawcross</a> <a href="/ReibergerThomas/">Thomas Reiberger</a> <a href="/ThomasBerg24/">Thomas Berg</a> <a href="/aelsharkawy75/">Ahmed Elsharkawy</a> <a href="/Apichatka/">Dr.Bornie</a> #Decompensation was once seen as the end of the road.🛣️
Now we know that even patients with decompensated liver disease can improve, and sometimes even reverse cirrhosis.

💡We are starting to understand the mechanisms driving this shift.

<a href="/EASLnews/">EASLnews</a>
#EASLstudio #EASLcongress
Mapi Ballester (@mapibafe) 's Twitter Profile Photo

Join us at the poster tour: cirrhosis and its complications. Track Hub 4, Friday 16:15-17:00 CEST. #AMMON to predict liver-related complications 🎯 EASLnews Thomas Reiberger Prof Rajiv Jalan

Join us at the poster tour: cirrhosis and its complications. Track Hub 4, Friday 16:15-17:00 CEST. #AMMON to predict liver-related complications 🎯 <a href="/EASLnews/">EASLnews</a> <a href="/ReibergerThomas/">Thomas Reiberger</a> <a href="/RajivJalan1/">Prof Rajiv Jalan</a>
EASL Education (@easledu) 's Twitter Profile Photo

📢 The first-ever EASL Clinical Practice Guidelines on #TIPS in #cirrhosis have just been presented by Virginia & Christophe Bureau Covered in the guidelines: ✔️ When to use preemptive TIPS ✔️ Guideline-supported use in: refractory ascites, hepatic hydrothorax, variceal

📢 The first-ever EASL Clinical Practice Guidelines on #TIPS in #cirrhosis have just been presented by <a href="/VirginiaHdezGea/">Virginia</a> &amp; Christophe Bureau

Covered in the guidelines:
✔️ When to use preemptive TIPS
✔️ Guideline-supported use in: refractory ascites, hepatic hydrothorax, variceal
EASL Education (@easledu) 's Twitter Profile Photo

📢 Just presented by Mattias Mandorfer and Dominique Thabut at #EASLCongress 2025: 🔥🔥First-ever EASL CPGs on extrahepatic abdominal surgery in patients with #cirrhosis & #ACLD Key recommendations: ✔️ Go beyond MELD/Child: assess VO₂peak, HVPG, frailty ✔️ Use VOCAL-Penn to

📢 Just presented by <a href="/MattiasMandorf1/">Mattias Mandorfer</a> and Dominique Thabut at #EASLCongress 2025: 
🔥🔥First-ever EASL CPGs on extrahepatic abdominal surgery in patients with #cirrhosis &amp; #ACLD

Key recommendations:
✔️ Go beyond MELD/Child: assess VO₂peak, HVPG, frailty
✔️ Use VOCAL-Penn to
Thomas Reiberger (@reibergerthomas) 's Twitter Profile Photo

What a pleasure to meet many friends and colleagues during EASLnews #EASLcongress 2025 in Amsterdam. A special last minute surprise was Prof. Tung-Hung Su from Taiwan.

What a pleasure to meet many friends and colleagues during <a href="/EASLnews/">EASLnews</a> #EASLcongress 2025 in Amsterdam. A special last minute surprise was Prof. Tung-Hung Su from Taiwan.
EASLnews (@easlnews) 's Twitter Profile Photo

Ready to rethink #MASLD care?🤔 Register for the next #EASLDeepDive to explore: 🔹 Pathophysiology & progression 🔹 Unmet clinical needs 🔹 Emerging therapies & endpoints 🗓️ 10 June, 18:00 CEST 🔗 easl-eu.zoom.us/webinar/regist… Gyorgy Baffy Sven Francque Thomas Reiberger

Ready to rethink #MASLD care?🤔

 Register for the next #EASLDeepDive to explore:
  🔹 Pathophysiology &amp; progression
  🔹 Unmet clinical needs
  🔹 Emerging therapies &amp; endpoints

🗓️ 10 June, 18:00 CEST
🔗 easl-eu.zoom.us/webinar/regist…

<a href="/gbaffy/">Gyorgy Baffy</a> <a href="/FrancqueSven/">Sven Francque</a> <a href="/ReibergerThomas/">Thomas Reiberger</a>
Thomas Berg (@thomasberg24) 's Twitter Profile Photo

🩸 New data add to current evidence on #PlasmaExchange in ACLF: TPE may improve short-term survival in selected patients unresponsive ☞ More work needed to define who benefits & when #LiverTwitter #EASL #INASL #EFCLIF jcehepatology.com/article/S0973-…

🩸 New data add to current evidence on #PlasmaExchange in ACLF:
TPE may improve short-term survival in selected patients unresponsive
☞ More work needed to define who benefits &amp; when #LiverTwitter #EASL #INASL #EFCLIF
jcehepatology.com/article/S0973-…
EASLnews (@easlnews) 's Twitter Profile Photo

Register for this #EASLDeepDive to learn all about the pathophysiology and clinical progression of #MASLD. Key topics include: 🔑Unmet Clinical Needs 🔑Valuable clinical endpoints 🔑Emerging therapies to improve patient care 🔗 easl-eu.zoom.us/webinar/regist… Gyorgy Baffy Sven Francque

Register for this #EASLDeepDive to learn all about the pathophysiology and clinical progression of #MASLD. 

Key topics include: 
🔑Unmet Clinical Needs
🔑Valuable clinical endpoints 
🔑Emerging therapies to improve patient care

🔗 easl-eu.zoom.us/webinar/regist…

<a href="/gbaffy/">Gyorgy Baffy</a> <a href="/FrancqueSven/">Sven Francque</a>
Thomas Reiberger (@reibergerthomas) 's Twitter Profile Photo

⚠️ #Hepatitis C Elimination EASLnews World Health Organization (WHO) The Lancet Gastroenterology & Hepatology 😑 not all countries have national HCV action plans ☹️ 36% have (partial) restrictions on curative #HCV treatments 😑 30% met HCV #WHO diagnosis coverage target of 60% ☹️ only 15% met HCV #WHO treatment target

⚠️ #Hepatitis C Elimination
<a href="/EASLnews/">EASLnews</a> <a href="/WHO/">World Health Organization (WHO)</a> 
<a href="/LancetGastroHep/">The Lancet Gastroenterology & Hepatology</a> 

😑 not all countries have national HCV action plans
☹️ 36% have (partial) restrictions on curative #HCV treatments
😑 30% met HCV #WHO diagnosis coverage target of 60%
☹️ only 15% met HCV #WHO treatment target
Thomas Reiberger (@reibergerthomas) 's Twitter Profile Photo

⚠️ #Hepatitis B Elimination EASLnews World Health Organization (WHO) The Lancet Gastroenterology & Hepatology 😑 73% met #WHO criterion of ≤0.5% HBsAg prevalence 😑 67% have universal #HBV birth vaccinations ☹️ Suboptimal #WHO diagnosis coverage target of 60% 😱 no country met #HBV treatment target

⚠️ #Hepatitis B Elimination
<a href="/EASLnews/">EASLnews</a> <a href="/WHO/">World Health Organization (WHO)</a> 
<a href="/LancetGastroHep/">The Lancet Gastroenterology & Hepatology</a> 

😑 73% met #WHO criterion of ≤0.5% HBsAg prevalence
😑 67% have universal #HBV birth vaccinations
☹️ Suboptimal #WHO diagnosis coverage target of 60%
😱 no country met #HBV treatment target
EASLnews (@easlnews) 's Twitter Profile Photo

EASL has released new CPGs on abdominal extrahepatic surgery in patients with cirrhosis and advanced chronic liver disease at #EASLCongress—a critical step in improving surgical outcomes for this high-risk population. 🏥🩺 🔍 Why it matters: As non-hepatic abdominal surgeries

EASL has released new CPGs on abdominal extrahepatic surgery in patients with cirrhosis and advanced chronic liver disease at #EASLCongress—a critical step in improving surgical outcomes for this high-risk population. 🏥🩺

🔍 Why it matters:
As non-hepatic abdominal surgeries
Thomas Reiberger (@reibergerthomas) 's Twitter Profile Photo

Study published in JHEP Reports MedUni Wien Vienna Liver News and Medizinische Hochschule Hannover Benjamin Maasoumy Minimal residual ascites 3 months after #TIPS implantation implicates worse clinical outcome in patients with #liver #cirrhosis 🔗sciencedirect.com/science/articl…

Study published in <a href="/JHEP_Reports/">JHEP Reports</a> 
<a href="/MedUni_Wien/">MedUni Wien</a> <a href="/ViennaLiverNews/">Vienna Liver News</a> 
and Medizinische Hochschule Hannover
<a href="/b_maasoumy/">Benjamin Maasoumy</a> 

Minimal residual ascites 3 months after #TIPS implantation implicates worse clinical outcome in patients with #liver #cirrhosis 

🔗sciencedirect.com/science/articl…
Thomas Reiberger (@reibergerthomas) 's Twitter Profile Photo

📈Activation #Vasopressin in #Cirrhosis tries to compensate🫀#hemodynamic &#sodium #fluid abnormalities Drs. HARTL & HINTERSTEININGER of MedUni Wien in🤝w/ efclif.com show in📕CGH 🔗 t.ly/joCs5 ▶️#Vasopressin biomarker #COPEPTIN predicts #ACLF

📈Activation #Vasopressin in #Cirrhosis tries to compensate🫀#hemodynamic &amp;#sodium #fluid abnormalities

Drs. HARTL &amp; HINTERSTEININGER of <a href="/MedUni_Wien/">MedUni Wien</a>  
in🤝w/ efclif.com show in📕<a href="/AGA_CGH/">CGH</a> 
🔗 t.ly/joCs5

▶️#Vasopressin biomarker #COPEPTIN predicts #ACLF